ctrl K

Price Alert

Avalo Therapeutics Inc. (AVTX)

NASDAQ: AVTX · Real-Time Price · USD

9.05

0.10 (1.12%)

At close: Aug 15, 2025, 3:59 PM

9.24

2.10%

After-hours: Aug 15, 2025, 07:50 PM EDT

Avalo Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	134.55M	7.42M	13.17M	54.59M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	131K	227K
Other Long-Term Assets	131K	131K	131K	1.23M
Receivables	611K	136K	1.92M	4.8M
Inventory	n/a	n/a	20K	38K
Other Current Assets	3.73M	844K	1.3M	51K
Total Current Assets	138.89M	8.39M	16.42M	61.84M
Property-Plant & Equipment	1.21M	1.97M	2.41M	2.69M
Goodwill & Intangibles	10.5M	10.5M	14.41M	14.45M
Total Long-Term Assets	11.84M	12.6M	16.95M	18.37M
Total Assets	150.73M	20.99M	33.37M	80.21M
Account Payables	283K	446K	2.88M	3.37M
Deferred Revenue	n/a	n/a	88K	16.02M
Short-Term Debt	n/a	n/a	5.93M	n/a
Other Current Liabilities	3.24M	3.06M	9.98M	1.74M
Total Current Liabilities	6.96M	4.62M	22.11M	19.89M
Long-Term Debt	n/a	n/a	13.49M	32.83M
Other Long-Term Liabilities	10.47M	8.92M	8.54M	4.3M
Total Long-Term Liabilities	10.74M	9.07M	22.17M	37.24M
Total Liabilities	17.7M	13.69M	44.28M	57.13M
Total Debt	568K	537K	19.42M	32.83M
Common Stock	10K	1K	9K	113K
Retained Earnings	-370.26M	-335.13M	-303.82M	-262.17M
Comprehensive Income	n/a	n/a	n/a	n/a
Shareholders Equity	133.03M	7.3M	-10.91M	23.08M
Total Investments	n/a	131K	131K	227K